β-Secretase (BACE1) inhibitors from Sanguisorbae Radix
In the course of screening anti-dementia agents from natural products, two β-secretase (BACE1) inhibitors were isolated from the ethyl acetate soluble fraction of Sanguisorbae Radix by the activity-guided purification using silica gel, Sephadex LH-20, and RP-HPLC. They were identified as 1,2,3-trigalloyl-4,6-hexahydroxydiphenoyl-β-d-glucopyranoside (Tellimagrandin II,1) and 1,2,3,4,6-pentagalloyl-β-d-glucopyranoside (2) and were shown to non-competitively inhibit β-secretase (BACE1) with the IC50 values of 3.10×10−6 M and 3.76×10−6 M, respectively. TheKi values of1 and2 were 6.84×10−6 M and 5.13×10−6 M. They were less inhibitory to α-secretase (TACE) and other serine proteases such as chymotrypsin, trypsin, and elastase, suggesting that they were relatively specific inhibitors of BACE1.
Key wordsβ-Secretase (BACE1) Inhibitor Sanguisorbae Radix Tellimagrandin II 1,2,3,4,6-Pentagalloyl-β-d-glucopyranoside Alzheimer's disease
Unable to display preview. Download preview PDF.
- Kim, S.-I. and Song, K.-S., 1,2,3,4,6-Pentagalloyl-β-d-glucopyranose, a prolyl endopeptidase inhibitor from Moutan cortex.J. Korean Soc. Agric. Chem. Biotechnol., 43, 158–161 (2000).Google Scholar
- Terry, R. D., Masliah, E., and Hansen, L. A., The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations, in: R. D. Terryet al. (Ed.), Alzheimer Disease, Lippincott, Williams and Wilkins, Philadelphia, pp. 187–206 (1999).Google Scholar